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We present the performance of Portuguese laboratories participating in the Labquality/PNAEQ organized EQA for C. trachomatis and N. gonorrhoeae nucleic acid 
detection. We analyzed which methods were used to determine C. trachomatis and N. gonorrhoeae in the last 5 years (2008-2012) and compared performances 
between Portuguese participants and participants from other European countries. 
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Performance of Portuguese laboratories in 
Labquality/PNAEQ EQA schemes for N. gonorrhoeae and  
C. trachomatis nucleic acid detection 
In the EQA schemes included in this retrospective study (2008-2012) three trial samples were distributed quarterly each year to the participating laboratories. Trial 
samples were swabs or liquid specimens,  with or without C. trachomatis and with or without N. gonorrhoeae. Participating laboratories should follow a protocol 
provided by Labquality- PNAEQ ​​for specimen handling, and should return their results in absorbance values and also provide the corresponding interpretation 
(positive/negative). In the last couple of years the participants were also asked to give information concerning positive results confirmation testing.   
Labquality provided the expected results and the performance achieved to each participating laboratory, together with a global evaluation (including statistical analysis). 
The results of the Portuguese laboratories regarding EQA for C. trachomatis and N. gonorrhoeae nucleic acid amplification testing were analyzed in comparison to the 
obtained in other countries for the same trials. 
_In Portugal, eight laboratories participated in 
C. trachomatis and  seven in N. gonorrhoeae 
nucleic acid amplification EQA schemes. 
_The graphics 1 and 2 exhibit the Portuguese 
participation in both schemes. Graphics 3 
and 4 evidence the composition of the trials 
(pos/neg) and the correct/incorrect results 
obtained for C. trachomatis and N. 
gonorrhoeae.   
_60% incorrect results were reported for the 
N. gonorrhoeae survey, coinciding with 
samples containing N. cinereae (sample 2 
and 3 of 2009) 
_Portuguese participants mainly used five to 
six different methods for the detection of C. 
trachomatis and N. gonorrhoeae; for both, 
the Amplicor (Roche) was the most frequently 
used.  
_The majority of the results were consistent 
with the composition of the trial sample. 
 
Although the performance of laboratories was globally good, the number of laboratories participating in nucleic acid amplification EQA trials in Portugal is very 
low, emphasizing the need for a wider and nationwide participation.  
The results show that PNAEQ participating laboratories performance is much similar to the observed in other countries. 
All throughout the years we observed a change in the methods used among the participants from BD ProbeTec ET CT/GC and Amplicor to several different new 
test kits (GenProbe Aptima-combo 2 and Abbott RealTime). 
The performance of participants was better for N. gonorrhoeae EQA trials, evidencing the need for monitoring performance in order to implement better practices 
that should overcome technical or personal failures. 
 
The National External Quality Assessment Program (PNAEQ) includes the National Health Institute Dr. Ricardo Jorge (INSA, IP), which is legally responsible for 
the promotion, organization and coordination of External Quality Assessment Laboratory programs. 
PNAEQ has been collaborating with the Finnish peer Labquality, since 2000.  
In 2013 a Consortium between the two entities was signed, seeking closer working relationships, and the promotion of research and development in the area of 
external quality assessment. 
  
The participation of laboratories in interlaboratory EQA schemes not only facilitates diagnosis, therapeutic monitorization, and quality assessment and guidance, but it 
also improves performance and increases the  laboratory quality level, which will directly benefit the patient. 
Proficiency testing programs play a key role in the evaluation of clinical laboratories and of manufactured tests but, in the case of molecular biology testing, it is yet 
complicated to evaluate EQAS programs. 
 
The Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid detection EQA schemes were chosen for the evaluation of the performance of the Portuguese 
laboratories in the field of molecular biology.  
C. trachomatis and N. gonorrhoeae are responsible for urogenital infections causing cervicitis in women and urethritis in both men and women. Infections are mainly 
asymptomatic (~40% of men and ~70% of women for C. trachomatis, and ~10% of men and ~60% of women for N. gonorrhoeae). Therefore, most cases remain 
undetected and untreated, and can progress to serious complications, especially in women, such as pelvic inflammatory disease, tubal infertility and ectopic 
pregnancy, justifying the need for using very sensitive molecular biology methods for their screening and diagnosis. 
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